A three-year-old humanoid-robot maker starts an IPO process, signaling how fast the AI hardware market is trying to monetize.

The breach appears narrow on patient identity, but UK Wegovy approval arrives with new phishing risk for patients and HCPs.

A single photographed failure does not prove Asus is to blame, but it reopens the 12VHPWR melting debate.

SpaceX’s trading debut is expected to smash records, and DealBook wants to know what else it disrupts.

A two-day test at Marine Corps Air Station Yuma validated sensing, tracking, identification, and defeat at extended ranges.

The largest IPO on record launches on a day markets can’t decide what matters more: cash-market euphoria or geopolitical risk.

Barclays is paying to expand into young money education, buying GoHenry’s UK business from US fintech Acorns.

After SpaceX's $75B IPO and a $1.75T valuation, the SpaceX president hints at a future Tesla merger.

If PrEP already prevents HIV by 99%, why is “delivering it” still the hard part? This launch aims to fix that.

The coming SpaceX listing turns Hong Kong into a live test of who controls flows and how quickly they move.

The SpaceX IPO values the company around $1.77T and estimates Musk’s stake at $866.5B, with broad investor ripple effects.

Manchester starts the 2026 UK/Europe run as the tour threatens $1B-plus total gross and 10-figure club status.